Covered recipient · General Payments record
INNA HUSAIN
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2019–2024
$10,288.50
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,818.75 | 3 |
| Travel and Lodging | $1,758.57 | 4 |
| Food and Beverage | $471.17 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Smith & Nephew, Inc. | $6,894.82 | 11 |
| Integra LifeSciences Corporation | $2,800.00 | 1 |
| Acclarent, Inc | $131.80 | 1 |
| AERIN MEDICAL INC. | $109.43 | 2 |
| Phathom Pharmaceuticals, Inc. | $97.69 | 1 |
| GlaxoSmithKline, LLC. | $14.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acclarent, Inc | $131.80 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077574614 | CMS |
| AERIN MEDICAL INC. | $74.01 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144652612 | CMS |
| AERIN MEDICAL INC. | $35.42 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144652974 | CMS |
| GlaxoSmithKline, LLC. | $14.75 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116247844 | CMS |
| Integra LifeSciences Corporation | $2,800.00 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154000789 | CMS |
| Phathom Pharmaceuticals, Inc. | $97.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151074764 | CMS |
| Smith+Nephew, Inc. | $19.06 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149610401 | CMS |
| Smith+Nephew, Inc. | $948.81 | 07/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1149610415 | CMS |
| Smith+Nephew, Inc. | $1.95 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149610399 | CMS |
| Smith+Nephew, Inc. | $28.43 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149610403 | CMS |
| Smith+Nephew, Inc. | $39.12 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149610407 | CMS |
| Smith+Nephew, Inc. | $487.68 | 07/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1149610413 | CMS |
| Smith+Nephew, Inc. | $262.08 | 07/31/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1149610411 | CMS |
| Smith+Nephew, Inc. | $28.94 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149610405 | CMS |
| Smith+Nephew, Inc. | $60.00 | 08/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1149610409 | CMS |
| Smith+Nephew, Inc. | $1,718.75 | 08/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149610417 | CMS |
| Smith+Nephew, Inc. | $3,300.00 | 08/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149610419 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.